Medicine and Dentistry
Malignant Neoplasm
100%
Sarcoma
67%
Serositis
55%
Gut
46%
Prospective Cohort Study
33%
Diagnosis
31%
C Reactive Protein
27%
Immune Checkpoint Inhibitor
27%
Fatty Acid Binding Protein 2
26%
Postoperative Complication
26%
Disease
26%
Proton Therapy
25%
Gut Microbiome
24%
Interleukin-6
23%
Overall Survival
20%
Prevalence
19%
Prognostic Factor
19%
Chemoradiotherapy
19%
Interleukin 1beta
19%
Neoplasm
18%
Quality of Life
18%
Hazard Ratio
17%
Enteric Feeding
15%
Inflammatory Bowel Disease
13%
Surgery
13%
Cancer Recurrence
13%
Paneth Cell
13%
Anastomosis Leakage
13%
Nodular Melanoma
13%
Social Interaction
13%
Graft Versus Host Reaction
13%
Colitis
13%
Surgical Technique
13%
Oncology
13%
Patient Attitude
13%
Mediterranean Diet
13%
Radiation Therapy
13%
Postoperative Delirium
13%
Walk Test
13%
Postoperative Cognitive Dysfunction
13%
Esophageal Cancer
13%
Immune Checkpoint Blockade
13%
Transcriptomics
13%
COVID-19
13%
Colon Cancer
13%
Cholecystokinin Receptor
13%
Odor
13%
Metabolism
13%
Metastatic Melanoma
13%
Flavor
13%
Keyphrases
Cancer Patients
59%
Survivors
53%
Esophageal Cancer
53%
Sarcoma
43%
Inflammatory Response
42%
Prospective Cohort Study
33%
Adult Sarcoma
26%
Postoperative Complications
26%
Older Adults
26%
Pneumonia
26%
Proton Radiotherapy
24%
Neoadjuvant Chemoradiotherapy (nCRT)
23%
Older Patients
22%
Diagnostic Interval
21%
Inflammatory Markers
20%
C-reactive Protein
19%
Radiotherapy
19%
Oncologic Surgery
18%
Dutch
18%
Risk Factors
17%
Netherlands
16%
Older Patients with Cancer
15%
Clinical Practice Guidelines
15%
Prognostic Factors
15%
Older Cancer Patients
14%
Health-related Quality of Life
14%
Patient Interval
14%
Plasma Parameters
13%
After Surgery
13%
Postoperative Cognitive Dysfunction
13%
Methotrexate Clearance
13%
Perceived Impact
13%
Factor Study
13%
Positive Engagement
13%
Checkpoint Inhibitor Colitis
13%
Surgery Complications
13%
Diagnostic Pathway
13%
Overall Survival
13%
Smell Alterations
13%
Prevalence Factors
13%
Patient Cohort
13%
Fear of Cancer Recurrence
13%
ANITA
13%
Transcriptional Pattern
13%
Biological Processes
13%
I-FABP
13%
Targeted Co-delivery
13%
Intestinal Integrity
13%
Oncology Patients
13%
Proton
13%